Related Experiment Video
Updated: Jul 11, 2026

Preparation of Agar Bead Embedded Mycobacterium abscessus to Inoculate Immunocompetent Mice Intratracheally
Published on: April 25, 2025
Pyogenic liver abscesses: mortality-related factors
José Juan Ruiz-Hernández1, Magdalena León-Mazorra, Alicia Conde-Martel
1Department of Internal Medicine, University Hospital of Gran Canaria Dr Negrín, Las Palmas, Gran Canaria, Spain.
Goal:
To analyse the characteristics and mortality-related factors in a series of patients hospitalized for pyogenic liver abscess (PLA).
Background:
Pyogenic liver abscesses are infrequent but potentially life threatening. Factors related to mortality have been less studied.
Study:
The medical records of 84 patients, 56 men and 28 women, mean age of 64.4 years (SD: 14) who were hospitalized between 1992 and 2005 owing to a PLA were reviewed. The past medical history, clinical signs and symptoms, laboratory values, imaging studies, microbiological features, treatment, complications and mortality were recorded. Factors related to complications and mortality were analysed.
Results:
One or more bacteria were isolated in 65 patients (77.4%), being Streptococcus spp. (40.5%), Escherichia coli (27.4%), Klebsiella spp. (14.3%) and anaerobics (17.9%) the most frequent isolates. Complications developed in 60.7% of the cases, the most common one being a right pleural effusion (34.5%). Mortality rate was 19% (95% confidence interval: 10-28%). Mortality was associated with age (P=0.005), a previous history of coronary heart disease (P=0.016), absence of fever (P=0.001), development of sepsis and/or septic shock (P<0.001), raise of bilirubin levels (P=0.004), a biliary (P=0.035), or cryptogenetic origin (P=0.039), infection owing to E. coli (P=0.01) or to Candida (P=0.009) and development of pneumonia (P<0.001). Logistic regression revealed sepsis and/or septic shock as an independent risk factor for mortality.
Conclusions:
Mortality associated with PLA is high. The main risk factor for mortality is the development of sepsis and/or septic shock.
Insights
Pyogenic liver abscess (PLA) is a serious condition with a high mortality rate. Sepsis and/or septic shock are identified as the primary independent risk factor for mortality in PLA patients.
Area of Science:
- Infectious Diseases
- Hepatology
- Critical Care Medicine
Background:
- Pyogenic liver abscess (PLA) is a rare but life-threatening infection.
- Factors contributing to mortality in PLA patients require further investigation.
Purpose of the Study:
- To analyze the clinical characteristics of patients hospitalized with PLA.
- To identify factors associated with complications and mortality in PLA.
Main Methods:
- Retrospective review of medical records for 84 patients hospitalized with PLA between 1992 and 2005.
- Data collected included medical history, clinical presentation, laboratory values, imaging, microbiology, treatment, complications, and mortality.
- Statistical analysis was performed to identify risk factors for complications and mortality.
Main Results:
- The most common bacterial isolates were Streptococcus spp. (40.5%) and Escherichia coli (27.4%).
- Complications occurred in 60.7% of cases, with right pleural effusion being the most frequent.
- The overall mortality rate was 19%, significantly associated with age, coronary heart disease, absence of fever, sepsis/septic shock, elevated bilirubin, biliary/cryptogenetic origin, E. coli/Candida infection, and pneumonia.
Conclusions:
- Pyogenic liver abscess carries a substantial mortality risk.
- Sepsis and/or septic shock emerged as the principal independent risk factor for mortality in PLA patients.
Related Concept Videos
Brain Abscess l: Introduction
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Pancreatitis II: Pathophysiology
Acute Pancreatitis II: Clinical Manifestations and Management
Pneumonia III: Complications and Assessment
